Skip to content
Not evaluated by SAHPRA · For information & research use only · Not intended to diagnose, treat, cure or prevent any disease · Consult a healthcare professional
This product has not been evaluated by SAHPRA. For information purposes only — not intended to diagnose, treat, cure or prevent any disease.
← Back to shop
loading 3D…
PerformanceResearch vialNNMT inhibitorsmall moleculeNAD+adiposeresearch

Amino-1MQ

NNMT inhibitor for adipose and NAD+ research

R 845
10mg vial
1
Buy now →WhatsApp order
Suppresses lipogenesisIn 3T3-L1 adipocytes, dose-dependently suppressed lipogenesis (50% at 30 µM, 70% at 60 µM).
Adipose-tissue effects in mice11 days of dosing in diet-induced obese mice produced ~5% body-weight loss and ~35% reduction in epididymal white adipose mass.
Raises intracellular NAD+ and SAMBlocking NNMT spares NAD+ precursors and methyl donors that the enzyme normally consumes.
Independent of food intakeMouse weight loss occurred without changes in food intake — a metabolic, not appetite, mechanism.
"Amino" in research-peptide catalogues at this price point and dose is the small-molecule **5-amino-1-methylquinolinium (5-Amino-1MQ)** — a selective inhibitor of nicotinamide N-methyltransferase (NNMT). It is not a peptide; it is a quinolinium scaffold sold alongside peptides because it is used in the same body-composition research context. NNMT methylates nicotinamide into 1-methylnicotinamide, consuming both NAD+ precursors and methyl donors. Inhibiting it raises intracellular NAD+ and SAM, and in adipocytes it suppresses lipogenesis.
More in Performance

You might also like

PerformanceR 715
CJC-1295 + Ipamorelin
10mg vial

CJC-1295 + Ipamorelin

A two-peptide blend pairing the GHRH analog CJC-1295 (without DAC / Modified GRF 1-29) with the selective ghrelin-receptor agonist Ipamorelin. CJC-1295 lifts the baseline of pulsatile GH release; Ipamorelin amplifies pulse amplitude without driving cortisol, prolactin or ACTH. Dual-receptor stimulation produces a GH response greater than the sum of either alone.

View details →
PerformanceR 520
Ipamorelin
5mg vial

Ipamorelin

Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) and a selective agonist of the growth-hormone-secretagogue receptor (GHS-R1a) — the same receptor targeted by ghrelin. It triggers pulsatile GH release without the ACTH, cortisol and prolactin spikes seen with older GHRPs (GHRP-2, GHRP-6, hexarelin).

View details →
PerformanceR 585
Hexarelin
5mg vial

Hexarelin

Hexarelin is a synthetic hexapeptide analog of GHRP-6 and a potent agonist of the growth-hormone-secretagogue receptor (GHS-R1a). It also binds the non-GHS-R receptor CD36, which underlies a separate cardiac action that does not depend on GH release. Of the older GHRPs it produces the strongest GH pulse.

View details →
Distributor
Elegant Slimming · Mokopane, Limpopo, South Africa
WhatsApp 076 547 8764 · Mon–Sat 9–5
Regulatory
This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA).
For information purposes only — not intended to diagnose, treat, cure or prevent any disease.